{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:32:45Z","timestamp":1779233565317,"version":"3.51.4"},"reference-count":17,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>An elderly woman with metastatic breast cancer was admitted with hyperglycaemic hyperosmolar state (HHS) and an elevated haemoglobin A1C. For 1 week, she had experienced confusion, nausea and frequent urination. Preceding this, she had completed seven cycles of capecitabine chemotherapy for her breast cancer. She did not have a history of diabetes prior to chemotherapy. Given the temporal dysglycaemia following the patient\u2019s chemotherapy regimen, capecitabine was thought to be a probable offending agent. The patient was acutely treated for HHS, and was discharged on a basal-bolus insulin regimen. Her capecitabine was held pending review with her oncology team. The patient was ultimately titrated down to basal insulin only by her family doctor. Given the common use of capecitabine, it is important to recognise the risk of hyperglycaemic and hyperglycaemic emergencies as potential adverse effects. This highlights the need to monitor blood glucose throughout treatment to prevent hyperglycaemic emergencies.<\/jats:p>","DOI":"10.1136\/bcr-2020-241109","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T12:49:17Z","timestamp":1616590157000},"page":"e241109","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Capecitabine-induced hyperosmolar hyperglycaemic state"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-9677","authenticated-orcid":false,"given":"Carly","family":"Yim","sequence":"first","affiliation":[{"name":"Medicine, Division of Endocrinology, University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassrein","family":"Hussein","sequence":"additional","affiliation":[{"name":"Medicine, Division of Endocrinology, University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-7713","authenticated-orcid":false,"given":"Terra","family":"Arnason","sequence":"additional","affiliation":[{"name":"Medicine, Division of Endocrinology, University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"2025082703471206000_14.3.e241109.1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases . LiverTox: clinical and research information on drug-induced liver injury. pyrimidine analogues. Bethesda (MD), 2012."},{"key":"2025082703471206000_14.3.e241109.2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214532508"},{"key":"2025082703471206000_14.3.e241109.3","doi-asserted-by":"publisher","DOI":"10.1159\/000342382"},{"key":"2025082703471206000_14.3.e241109.4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00228-017-2304-5","article-title":"Capecitabine-Induced hyperglycemia without hyperlipidemia: a case report","volume":"73","author":"Avishek","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2025082703471206000_14.3.e241109.5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-Induced hyperglycaemia and diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Saf"},{"key":"2025082703471206000_14.3.e241109.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00058-6"},{"key":"2025082703471206000_14.3.e241109.7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2169\/internalmedicine.54.3413","article-title":"The development of fulminant type 1 diabetes during chemotherapy for rectal cancer","volume":"54","author":"Adachi","year":"2015","journal-title":"Intern Med"},{"key":"2025082703471206000_14.3.e241109.8","first-page":"189","article-title":"Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: a case report","volume":"11","author":"Iwata","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"2025082703471206000_14.3.e241109.9","first-page":"675","article-title":"Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver","volume":"7","author":"Komatsu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2025082703471206000_14.3.e241109.10","doi-asserted-by":"publisher","DOI":"10.1177\/1078155209344650"},{"key":"2025082703471206000_14.3.e241109.11","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.8.1076.32870"},{"key":"2025082703471206000_14.3.e241109.12","first-page":"526","article-title":"Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?","volume":"18","author":"Chan","year":"2012","journal-title":"Hong Kong Med J"},{"key":"2025082703471206000_14.3.e241109.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2012.03097.x"},{"key":"2025082703471206000_14.3.e241109.14","first-page":"935","article-title":"[Impact of 5-fluorouracil on glucose metabolism and pancreatic pathology in rats]","volume":"13","author":"Feng","year":"2010","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"2025082703471206000_14.3.e241109.15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025082703471206000_14.3.e241109.16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jso.22009","article-title":"Metastases to the pancreas: the experience of a high volume center and a review of the literature","volume":"105","author":"Alzahrani","year":"2012","journal-title":"J Surg Oncol"},{"key":"2025082703471206000_14.3.e241109.17","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jcjd.2017.10.013","article-title":"Hyperglycemic emergencies in adults","volume":"42","author":"Goguen","year":"2018","journal-title":"Can J Diabetes"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-241109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:47:19Z","timestamp":1756291639000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-241109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,24]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/bcr-2020-241109"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-241109","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}